Featured Stories

News
Chargemaster Pricing for Treatments May Be Misleading
January 16, 2020
A JAMA Oncology study shows that hospital list pricing posted online, which is referred to as a chargemaster, is often significantly different than what a patient is billed.
News
CVS Health Publishes Methods to Reduce Gene Therapy Costs
January 16, 2020
In a recent white paper, CVS Health outlined four strategies that could improve patient access and care, as well as lead to significant payer cost…
News
High-Deductible Plans Put Patients and Hospitals at Risk in Rural Communities
January 15, 2020
In rural areas, high-deductible health plans threaten patients' financial heath, but they are not the only ones; hospitals are also experiencing…
News
Hematologic Cancer Progression Increases Health Care Costs
January 15, 2020
“New treatments that delay disease progression in patients with hematologic cancer could have a significant impact on the economic burden of…
News
Lower Costs, Improved Survival Linked With Nonmyeloablative Conditioning for AML
January 15, 2020
Nonmyeloablative conditioning was associated with lower reimbursement and improved overall survival 1 year after allogeneic hematopoietic cell…
News
Eli Lilly to Launch Half-Priced Versions of Two More Insulin Treatments
January 14, 2020
Continuing the effort to increase access for patients, Eli Lilly will be offering two new half-priced versions of its Humalog Junior KwikPen and…
News
FDA Approves Blueprint's Stomach Cancer Therapy Priced at $32,000 Per Month
January 10, 2020
After receiving FDA approval as the first treatment for patients with a rare form of stomach cancer, Blueprint Medicine Corp's Ayvakit was priced at…
Back to Top